DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE

DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE was reported 879 times

DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DRUG METABOLISING ENZYME TEST ABNORMAL 1 0.0476
1 PRECANCEROUS LESION EXCISION 1 0.0385
2 DRUG METABOLISING ENZYME INCREASED 1 0.0345
3 NAIL PICKING 1 0.0222
4 PH BODY FLUID DECREASED 1 0.0217
5 COMPULSIVE CHEEK BITING 1 0.0196
6 ADVERSE EVENT FOLLOWING IMMUNISATION 1 0.0179
7 POSTMORTEM BLOOD DRUG LEVEL 1 0.0169
8 VULVOVAGINAL DISORDER 1 0.0164
9 ALCOHOLIC HANGOVER 1 0.0164
10 GINGIVAL PRURITUS 1 0.0116
11 UNEMPLOYMENT 2 0.0104
12 DERMATILLOMANIA 6 0.0101
13 ARTIFICIAL MENOPAUSE 1 0.0094
14 URINE AMPHETAMINE POSITIVE 3 0.0091
15 PROGESTERONE INCREASED 1 0.0090
16 HYPERTROPHY OF TONGUE PAPILLAE 1 0.0083
17 TESTICULAR OEDEMA 1 0.0075
18 PH BODY FLUID ABNORMAL 1 0.0072
19 AMPHETAMINES POSITIVE 4 0.0053
20 TANGENTIALITY 1 0.0052
21 UPPER RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0047
22 JOB DISSATISFACTION 3 0.0046
23 SOCIAL ANXIETY DISORDER 3 0.0046
24 BLOOD ETHANOL INCREASED 1 0.0045
25 SENSORY LEVEL ABNORMAL 1 0.0044
26 THERAPEUTIC PRODUCT EFFECT PROLONGED 2 0.0044
27 SPLINTER 1 0.0043
28 INABILITY TO AFFORD MEDICATION 43 0.0043
29 POST VIRAL FATIGUE SYNDROME 1 0.0041
30 ANAL INFECTION 1 0.0039
31 THERAPEUTIC PRODUCT EFFECT VARIABLE 15 0.0039
32 RETINITIS PIGMENTOSA 1 0.0038
33 LAPAROSCOPY 1 0.0038
34 HYPERMETABOLISM 2 0.0038
35 TEETHING 1 0.0033
36 CHANGE IN SUSTAINED ATTENTION 1 0.0033
37 DEFIANT BEHAVIOUR 1 0.0032
38 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
39 PATIENT ELOPEMENT 1 0.0027
40 ESSENTIAL THROMBOCYTHAEMIA 1 0.0027
41 SKIN DISCHARGE 1 0.0026
42 PHYSICAL EXAMINATION ABNORMAL 1 0.0026
43 INSURANCE ISSUE 39 0.0025
44 CHRONIC HEPATITIS C 1 0.0025
45 OPPOSITIONAL DEFIANT DISORDER 1 0.0025
46 PERIPHERAL CIRCULATORY FAILURE 1 0.0024
47 BELLIGERENCE 1 0.0023
48 COUNTERFEIT PRODUCT ADMINISTERED 3 0.0023
49 DELUSION OF GRANDEUR 1 0.0022
50 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0022
51 OPIATES POSITIVE 1 0.0021
52 PRODUCT AVAILABILITY ISSUE 47 0.0021
53 HYPERMOBILITY SYNDROME 1 0.0020
54 ANTISOCIAL BEHAVIOUR 2 0.0020
55 HYPOHIDROSIS 1 0.0020
56 GINGIVAL DISCOLOURATION 1 0.0019
57 BINGE EATING 2 0.0019
58 AUTOSCOPY 1 0.0019
59 EXECUTIVE DYSFUNCTION 1 0.0018
60 DRUG EFFECT PROLONGED 1 0.0018
61 DISTRACTIBILITY 2 0.0017
62 MENTAL DISABILITY 1 0.0017
63 THYROID CYST 1 0.0017
64 PRODUCT ADMINISTRATION INTERRUPTED 13 0.0017
65 SACRAL PAIN 1 0.0016
66 PREMATURE EJACULATION 1 0.0016
67 GINGIVAL DISCOMFORT 1 0.0015
68 HALLUCINATION, TACTILE 1 0.0015
69 PERSONAL RELATIONSHIP ISSUE 1 0.0015
70 NEURODEVELOPMENTAL DISORDER 1 0.0015
71 CERVIX DISORDER 1 0.0014
72 DENTAL RESTORATION FAILURE 1 0.0014
73 EYELID FUNCTION DISORDER 1 0.0013
74 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
75 EDUCATIONAL PROBLEM 2 0.0012
76 LAZINESS 2 0.0012
77 INFUSION SITE DISCOLOURATION 1 0.0011
78 DRUG LEVEL FLUCTUATING 1 0.0011
79 YAWNING 3 0.0011
80 TIC 6 0.0011
81 BONE GRAFT 1 0.0011
82 WRIST SURGERY 1 0.0011
83 NEGATIVE THOUGHTS 3 0.0010
84 AFFECTIVE DISORDER 8 0.0010
85 SUSPECTED COUNTERFEIT PRODUCT 4 0.0010
86 SKIN SENSITISATION 1 0.0010
87 SLEEP DEFICIT 2 0.0009
88 PRODUCT PHYSICAL ISSUE 19 0.0009
89 BLADDER DILATATION 1 0.0009
90 DRUG EFFECT VARIABLE 1 0.0009
91 DYSLEXIA 1 0.0009
92 FRUSTRATION TOLERANCE DECREASED 7 0.0009
93 NECK SURGERY 2 0.0009
94 TOOTH EROSION 1 0.0008
95 PROTEIN TOTAL ABNORMAL 1 0.0008
96 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
97 ENURESIS 3 0.0007
98 BRUXISM 4 0.0007
99 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
100 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
101 CATAPLEXY 1 0.0007
102 JUDGEMENT IMPAIRED 1 0.0007
103 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
104 PANCREATIC ENZYMES INCREASED 1 0.0007
105 SLEEP PARALYSIS 1 0.0007
106 DARK CIRCLES UNDER EYES 1 0.0007
107 PRECANCEROUS SKIN LESION 1 0.0007
108 THERAPEUTIC RESPONSE SHORTENED 22 0.0007
109 LOSS OF EMPLOYMENT 2 0.0007
110 DRUG EFFECT DELAYED 3 0.0007
111 ORAL MUCOSAL EXFOLIATION 1 0.0007
112 DISSOCIATION 5 0.0007
113 PREMATURE SEPARATION OF PLACENTA 1 0.0006
114 DAYDREAMING 1 0.0006
115 EYE ALLERGY 1 0.0006
116 SUBSTANCE USE 1 0.0006
117 NASAL ULCER 1 0.0006
118 NEAR DEATH EXPERIENCE 2 0.0006
119 POST-TRAUMATIC STRESS DISORDER 4 0.0006
120 DRUG TOLERANCE 3 0.0006
121 PRODUCT LABEL ISSUE 4 0.0006
122 CERVICAL SPINAL STENOSIS 1 0.0006
123 TACHYPHRENIA 2 0.0006
124 DISTURBANCE IN ATTENTION 31 0.0006
125 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
126 LOGORRHOEA 2 0.0006
127 TERMINAL INSOMNIA 1 0.0006
128 FEAR OF DISEASE 1 0.0006
129 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
130 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
131 DISORGANISED SPEECH 1 0.0005
132 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
133 LYMPH NODE PAIN 1 0.0005
134 IMPULSIVE BEHAVIOUR 2 0.0005
135 NARCOLEPSY 1 0.0005
136 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
137 ALCOHOL INTERACTION 1 0.0005
138 MULTI-ORGAN DISORDER 1 0.0005
139 IMPULSE-CONTROL DISORDER 1 0.0005
140 SUICIDAL BEHAVIOUR 2 0.0005
141 PRE-EXISTING CONDITION IMPROVED 3 0.0005
142 INFUSION SITE BRUISING 1 0.0005
143 BIPOLAR DISORDER 5 0.0005
144 PRODUCT FORMULATION ISSUE 3 0.0005
145 DENTAL CARIES 5 0.0005
146 FEAR OF DEATH 1 0.0004
147 READING DISORDER 1 0.0004
148 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
149 MIDDLE INSOMNIA 8 0.0004
150 ESCHERICHIA BACTERAEMIA 1 0.0004
151 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
152 FEELING JITTERY 8 0.0004
153 EYE OEDEMA 1 0.0004
154 CEREBRAL DISORDER 3 0.0004
155 DENTAL OPERATION 1 0.0004
156 DERMATOMYOSITIS 1 0.0004
157 HOSTILITY 1 0.0004
158 SEDATION COMPLICATION 1 0.0004
159 ANGLE CLOSURE GLAUCOMA 1 0.0004
160 EUPHORIC MOOD 4 0.0004
161 INITIAL INSOMNIA 4 0.0004
162 MENOPAUSE 1 0.0004
163 ANGER 13 0.0004
164 PERSONALITY DISORDER 1 0.0004
165 FOOD CRAVING 2 0.0004
166 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
167 NONSPECIFIC REACTION 2 0.0004
168 PLEURITIC PAIN 1 0.0004
169 MACULE 1 0.0004
170 IRRITABILITY 21 0.0003
171 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
172 THERAPEUTIC REACTION TIME DECREASED 1 0.0003
173 SEXUAL DYSFUNCTION 4 0.0003
174 TOOTH DISCOLOURATION 1 0.0003
175 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
176 URINE ANALYSIS ABNORMAL 1 0.0003
177 ACNE CYSTIC 1 0.0003
178 DYSCHEZIA 1 0.0003
179 BRAIN FOG 5 0.0003
180 FOREIGN BODY IN THROAT 1 0.0003
181 INFUSION SITE PRURITUS 1 0.0003
182 DRUG EFFECT INCREASED 1 0.0003
183 INTENTIONAL DOSE OMISSION 9 0.0003
184 TESTICULAR PAIN 1 0.0003
185 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
186 LYMPHOCYTE COUNT INCREASED 1 0.0003
187 THERAPY CHANGE 3 0.0003
188 SOMNAMBULISM 2 0.0003
189 TONGUE ULCERATION 1 0.0003
190 HANGOVER 1 0.0003
191 HEAD DISCOMFORT 5 0.0003
192 HEREDITARY ANGIOEDEMA 3 0.0003
193 PANIC REACTION 2 0.0003
194 SPONDYLITIS 1 0.0003
195 APATHY 4 0.0003
196 ALCOHOL USE 1 0.0003
197 TENDON INJURY 1 0.0003
198 HYPERACUSIS 1 0.0003
199 SEDATION 7 0.0003
200 PAROSMIA 2 0.0003
201 AUTOIMMUNE THYROIDITIS 1 0.0003
202 PRESCRIBED OVERDOSE 5 0.0003
203 CONCUSSION 2 0.0003
204 PANIC DISORDER 1 0.0003
205 APHTHOUS ULCER 2 0.0003
206 EPIGASTRIC DISCOMFORT 1 0.0003
207 SKIN ODOUR ABNORMAL 1 0.0003
208 NO ADVERSE EVENT 46 0.0003
209 DRUG SCREEN POSITIVE 2 0.0003
210 POLYDIPSIA 1 0.0003
211 TRIGEMINAL NEURALGIA 1 0.0002
212 SUBSTANCE ABUSE 2 0.0002
213 GOITRE 1 0.0002
214 HYPERAESTHESIA 2 0.0002
215 MENSTRUAL DISORDER 2 0.0002
216 SELF-INJURIOUS IDEATION 1 0.0002
217 WITHDRAWAL SYNDROME 10 0.0002
218 POOR PERIPHERAL CIRCULATION 1 0.0002
219 ALCOHOLISM 1 0.0002
220 MUSCULOSKELETAL DISCOMFORT 4 0.0002
221 TOOTH INJURY 1 0.0002
222 PRODUCT PRESCRIBING ISSUE 5 0.0002
223 GRIP STRENGTH DECREASED 2 0.0002
224 DEPRESSED MOOD 12 0.0002
225 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
226 FACIAL PAIN 2 0.0002
227 ANAL INCONTINENCE 2 0.0002
228 URINE ABNORMALITY 1 0.0002
229 PANIC ATTACK 8 0.0002
230 ABDOMINAL HERNIA 1 0.0002
231 DYSPAREUNIA 1 0.0002
232 PRODUCT DISTRIBUTION ISSUE 2 0.0002
233 PERFORMANCE STATUS DECREASED 1 0.0002
234 INSOMNIA 57 0.0002
235 UMBILICAL HERNIA 1 0.0002
236 SUSPECTED SUICIDE 1 0.0002
237 SKIN TIGHTNESS 1 0.0002
238 SARCOIDOSIS 1 0.0002
239 SLEEP APNOEA SYNDROME 4 0.0002
240 IMPAIRED QUALITY OF LIFE 3 0.0002
241 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
242 SOMNOLENCE 41 0.0002
243 DISABILITY 4 0.0002
244 FOOT OPERATION 1 0.0002
245 BLADDER DISORDER 2 0.0002
246 ANEURYSM 1 0.0002
247 HYPOAESTHESIA ORAL 3 0.0002
248 DYSPHORIA 1 0.0002
249 FEELING ABNORMAL 47 0.0002
250 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
251 TONSILLITIS 1 0.0002
252 HALLUCINATION, AUDITORY 3 0.0002
253 ANORECTAL DISCOMFORT 1 0.0002
254 IMPAIRED WORK ABILITY 4 0.0002
255 FOOD POISONING 1 0.0002
256 POOR QUALITY SLEEP 4 0.0002
257 PRODUCT RESIDUE PRESENT 1 0.0002
258 BEHAVIOUR DISORDER 1 0.0002
259 JAW DISORDER 1 0.0002
260 MANIA 3 0.0002
261 NECROSIS 1 0.0002
262 HEART RATE ABNORMAL 1 0.0002
263 REBOUND EFFECT 2 0.0002
264 PERIORBITAL SWELLING 1 0.0002
265 ABNORMAL BEHAVIOUR 7 0.0002
266 MICTURITION URGENCY 2 0.0002
267 CHOLECYSTECTOMY 2 0.0002
268 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
269 ANXIETY 49 0.0002
270 BRADYKINESIA 1 0.0002
271 PSYCHOTIC DISORDER 5 0.0002
272 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
273 SYMPTOM RECURRENCE 1 0.0002
274 DRUG EFFECT DECREASED 9 0.0002
275 DRUG INEFFECTIVE 219 0.0002
276 CRYING 6 0.0002
277 MENTAL IMPAIRMENT 4 0.0002
278 NOCTURIA 2 0.0002
279 SUICIDAL IDEATION 15 0.0002
280 EMOTIONAL DISORDER 5 0.0002
281 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
282 INFUSION SITE EXTRAVASATION 1 0.0002
283 DRY MOUTH 13 0.0002
284 AGGRESSION 8 0.0002
285 INFUSION SITE SWELLING 1 0.0002
286 INCOHERENT 1 0.0002
287 PRODUCT USE ISSUE 29 0.0002
288 BRADYPHRENIA 1 0.0002
289 PRODUCT PREPARATION ISSUE 1 0.0002
290 QUALITY OF LIFE DECREASED 2 0.0001
291 WRONG PRODUCT ADMINISTERED 1 0.0001
292 PRODUCT TASTE ABNORMAL 2 0.0001
293 IMPAIRED GASTRIC EMPTYING 2 0.0001
294 NEPHROTIC SYNDROME 1 0.0001
295 LYMPHOEDEMA 1 0.0001
296 EXTRASYSTOLES 1 0.0001
297 DUODENAL ULCER 1 0.0001
298 HAND FRACTURE 1 0.0001
299 PRODUCT SUPPLY ISSUE 1 0.0001
300 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
301 VISUAL FIELD DEFECT 1 0.0001
302 ANOSMIA 2 0.0001
303 PRODUCT DISPENSING ERROR 3 0.0001
304 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
305 MAJOR DEPRESSION 1 0.0001
306 ORAL DISORDER 1 0.0001
307 BLINDNESS TRANSIENT 1 0.0001
308 PSYCHIATRIC SYMPTOM 1 0.0001
309 ECONOMIC PROBLEM 2 0.0001
310 DEPRESSION 30 0.0001
311 MUSCLE TWITCHING 3 0.0001
312 TENDONITIS 2 0.0001
313 DELUSION 2 0.0001
314 APNOEA 1 0.0001
315 THERAPY PARTIAL RESPONDER 2 0.0001
316 NASAL DISCOMFORT 1 0.0001
317 THERAPY INTERRUPTED 9 0.0001
318 RENAL CYST 1 0.0001
319 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
320 ADVERSE DRUG REACTION 11 0.0001
321 PRODUCT SUBSTITUTION ISSUE 7 0.0001
322 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
323 AGEUSIA 3 0.0001
324 PALPITATIONS 14 0.0001
325 LIVE BIRTH 1 0.0001
326 UTERINE PERFORATION 1 0.0001
327 PRODUCT QUALITY ISSUE 16 0.0001
328 HYPOPHAGIA 3 0.0001
329 PARANOIA 2 0.0001
330 BLOOD MAGNESIUM DECREASED 1 0.0001
331 MUSCLE STRAIN 1 0.0001
332 NERVOUSNESS 6 0.0001
333 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
334 GALLBLADDER DISORDER 2 0.0001
335 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
336 PREGNANCY WITH CONTRACEPTIVE DEVICE 1 0.0001
337 THROAT TIGHTNESS 3 0.0001
338 AGITATION 8 0.0001
339 BRAIN NEOPLASM 1 0.0001
340 RETINAL DETACHMENT 1 0.0001
341 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
342 NERVE COMPRESSION 1 0.0001
343 IRON DEFICIENCY ANAEMIA 1 0.0001
344 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
345 PERSONALITY CHANGE 1 0.0001
346 THINKING ABNORMAL 2 0.0001
347 SQUAMOUS CELL CARCINOMA 1 0.0001
348 UNEVALUABLE EVENT 8 0.0001
349 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
350 SEROTONIN SYNDROME 2 0.0001
351 AFFECT LABILITY 1 0.0001
352 DRUG INTOLERANCE 10 0.0001
353 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
354 COELIAC DISEASE 1 0.0001
355 KNEE OPERATION 1 0.0001
356 EMBEDDED DEVICE 1 0.0001
357 OVARIAN CYST 1 0.0001
358 BRAIN INJURY 1 0.0001
359 DYSKINESIA 4 0.0001
360 DRUG LEVEL DECREASED 1 0.0001
361 EAR DISCOMFORT 1 0.0001
362 TOOTH LOSS 2 0.0001
363 ROAD TRAFFIC ACCIDENT 4 0.0001
364 PRODUCT ODOUR ABNORMAL 1 0.0001
365 KNEE ARTHROPLASTY 2 0.0001
366 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
367 HEAD INJURY 3 0.0001
368 HALLUCINATION, VISUAL 2 0.0001
369 RETCHING 2 0.0001
370 JOINT INJURY 2 0.0001
371 WOUND INFECTION 1 0.0001
372 BLOOD GLUCOSE FLUCTUATION 1 0.0001
373 GASTROINTESTINAL PAIN 1 0.0001
374 TOOTH FRACTURE 1 0.0001
375 NERVE INJURY 1 0.0001
376 HYPERTENSIVE CRISIS 1 0.0001
377 SKIN INFECTION 1 0.0001
378 PRODUCT DOSE OMISSION ISSUE 26 0.0001
379 IMPAIRED DRIVING ABILITY 1 0.0001
380 ILLNESS 9 0.0001
381 ADVERSE EVENT 8 0.0001
382 COGNITIVE DISORDER 4 0.0001
383 SPLENOMEGALY 1 0.0001
384 SPINAL PAIN 1 0.0001
385 SLEEP DISORDER 6 0.0001
386 HEADACHE 53 0.0001
387 BLOOD IRON DECREASED 1 0.0001
388 PRODUCT PRESCRIBING ERROR 2 0.0001
389 CHOLECYSTITIS 1 0.0001
390 ACCIDENT 1 0.0001
391 MUSCLE RIGIDITY 1 0.0001
392 DRUG EFFECT INCOMPLETE 3 0.0001
393 NEURALGIA 2 0.0001
394 RESPIRATORY DEPRESSION 1 0.0001
395 CYST 1 0.0001
396 HAIR COLOUR CHANGES 1 0.0001
397 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
398 DYSARTHRIA 3 0.0001
399 POISONING 1 0.0001
400 FATIGUE 61 0.0001
401 INFUSION SITE PAIN 1 0.0001
402 UNRESPONSIVE TO STIMULI 2 0.0001
403 SPEECH DISORDER 4 0.0001
404 JOINT STIFFNESS 2 0.0001
405 BEDRIDDEN 1 0.0001
406 ORAL CANDIDIASIS 1 0.0001
407 TOOTH INFECTION 1 0.0001
408 PANCREATITIS 4 0.0001
409 ADVERSE REACTION 1 0.0001
410 BLOOD BILIRUBIN INCREASED 2 0.0001
411 MOOD ALTERED 2 0.0001
412 AKATHISIA 1 0.0001
413 OSTEOPOROSIS 3 0.0001
414 PERIPHERAL COLDNESS 1 0.0001
415 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
416 APPLICATION SITE RASH 1 0.0001
417 TREATMENT FAILURE 6 0.0001
418 ORAL DISCOMFORT 1 0.0001
419 HYPOMAGNESAEMIA 1 0.0001
420 HUNGER 1 0.0001
421 COORDINATION ABNORMAL 1 0.0001
422 NECK PAIN 4 0.0001
423 MASS 1 0.0001
424 CARPAL TUNNEL SYNDROME 1 0.0001
425 TARDIVE DYSKINESIA 2 0.0001
426 SEASONAL ALLERGY 1 0.0001
427 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
428 PAIN IN JAW 2 0.0001
429 SINUS TACHYCARDIA 1 0.0001
430 HYPERHIDROSIS 9 0.0001
431 PARAESTHESIA ORAL 1 0.0001
432 HYPERTHYROIDISM 1 0.0001
433 HYPOKINESIA 1 0.0001
434 SURGERY 4 0.0001
435 IMMUNODEFICIENCY 1 0.0001
436 BONE LOSS 1 0.0001
437 BLOOD POTASSIUM DECREASED 2 0.0001
438 BLOOD COUNT ABNORMAL 1 0.0001
439 OSTEOPENIA 1 0.0001
440 DISCOMFORT 4 0.0001
441 SKIN DISCOLOURATION 3 0.0001
442 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
443 EXPOSURE DURING PREGNANCY 4 0.0001
444 SWOLLEN TONGUE 2 0.0001
445 PRODUCT USE COMPLAINT 1 0.0001
446 DISEASE RECURRENCE 3 0.0001
447 RESPIRATORY TRACT CONGESTION 1 0.0001
448 MIGRAINE 6 0.0001
449 PREMATURE DELIVERY 1 0.0001
450 OBESITY 1 0.0001
451 SCIATICA 1 0.0001
452 SENSORY DISTURBANCE 1 0.0001
453 HIP FRACTURE 2 0.0001
454 NIGHT SWEATS 2 0.0001
455 MUSCLE TIGHTNESS 1 0.0001
456 MULTIPLE FRACTURES 1 0.0001
457 HEART RATE INCREASED 6 0.0001
458 VENTRICULAR TACHYCARDIA 1 0.0001
459 DRUG LEVEL INCREASED 1 0.0001
460 DRY EYE 3 0.0001
461 CANDIDA INFECTION 1 0.0001
462 SCAR 1 0.0001
463 MEMORY IMPAIRMENT 8 0.0001
464 WEIGHT INCREASED 13 0.0001
465 PARAESTHESIA 9 0.0001
466 RASH MACULAR 2 0.0001
467 MUSCULOSKELETAL STIFFNESS 5 0.0001
468 HEART RATE DECREASED 2 0.0001
469 COLD SWEAT 1 0.0001
470 THIRST 1 0.0001
471 OFF LABEL USE 49 0.0001
472 GASTROINTESTINAL DISORDER 5 0.0001
473 COMPLICATION OF DEVICE REMOVAL 1 0.0001
474 OSTEOMYELITIS 1 0.0001
475 RESTLESS LEGS SYNDROME 1 0.0001
476 TREATMENT NONCOMPLIANCE 3 0.0001
477 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
478 RESTLESSNESS 2 0.0001
479 LOSS OF CONSCIOUSNESS 7 0.0001
480 DYSURIA 2 0.0001
481 TREMOR 9 0.0001
482 OROPHARYNGEAL PAIN 5 0.0001
483 CONJUNCTIVITIS 1 0.0001
484 BACTERIAL INFECTION 1 0.0001
485 SWELLING 5 0.0001
486 BLISTER 3 0.0001
487 BLOOD SODIUM DECREASED 1 0.0001
488 FLATULENCE 3 0.0001
489 FRACTURE 1 0.0001
490 CONDITION AGGRAVATED 16 0.0001
491 MUSCULOSKELETAL DISORDER 1 0.0001
492 DEHYDRATION 7 0.0001
493 INCREASED APPETITE 1 0.0001
494 LETHARGY 3 0.0001
495 DRUG PRESCRIBING ERROR 1 0.0001
496 COVID-19 9 0.0001
497 HAEMORRHOIDS 1 0.0001
498 CHOKING 1 0.0001
499 ORAL HERPES 1 0.0001
500 SKIN FISSURES 1 0.0001
501 KIDNEY INFECTION 1 0.0001
502 MENORRHAGIA 1 0.0001
503 SINUS DISORDER 1 0.0001
504 DISORIENTATION 2 0.0001
505 BLOOD PRESSURE ABNORMAL 1 0.0001
506 UPPER LIMB FRACTURE 1 0.0001
507 SYNCOPE 5 0.0000
508 PREGNANCY 1 0.0000
509 SPINAL FRACTURE 1 0.0000
510 FULL BLOOD COUNT DECREASED 1 0.0000
511 PRODUCT ADMINISTRATION ERROR 1 0.0000
512 EXTRA DOSE ADMINISTERED 2 0.0000
513 FEEDING DISORDER 1 0.0000
514 TASTE DISORDER 1 0.0000
515 VERTIGO 3 0.0000
516 BONE MARROW FAILURE 1 0.0000
517 FLUSHING 5 0.0000
518 NEUTROPHIL COUNT DECREASED 2 0.0000
519 PRODUCT PREPARATION ERROR 1 0.0000
520 RIB FRACTURE 1 0.0000
521 MALAISE 21 0.0000
522 DERMATITIS 1 0.0000
523 HYPERTENSION 10 0.0000
524 HYPOAESTHESIA 7 0.0000
525 IRRITABLE BOWEL SYNDROME 1 0.0000
526 MENTAL DISORDER 2 0.0000
527 PRODUCT DOSE OMISSION 3 0.0000
528 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
529 DRUG WITHDRAWAL SYNDROME 4 0.0000
530 BLOOD PRESSURE DECREASED 3 0.0000
531 TACHYCARDIA 4 0.0000
532 TOOTH DISORDER 1 0.0000
533 GLOSSODYNIA 1 0.0000
534 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
535 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
536 HEART RATE IRREGULAR 1 0.0000
537 NAUSEA 35 0.0000
538 VISION BLURRED 6 0.0000
539 NEPHROLITHIASIS 2 0.0000
540 TINNITUS 2 0.0000
541 NASOPHARYNGITIS 8 0.0000
542 DYSPHAGIA 4 0.0000
543 JOINT SWELLING 5 0.0000
544 HYPOGLYCAEMIA 2 0.0000
545 FIBROMYALGIA 1 0.0000
546 PRESYNCOPE 1 0.0000
547 LIVER INJURY 1 0.0000
548 DYSPEPSIA 4 0.0000
549 DYSGEUSIA 3 0.0000
550 HALLUCINATION 3 0.0000
551 ACNE 3 0.0000
552 INCORRECT DOSE ADMINISTERED 9 0.0000
553 FLUID RETENTION 2 0.0000
554 CHEST DISCOMFORT 4 0.0000
555 PERIPHERAL SWELLING 6 0.0000
556 ERECTILE DYSFUNCTION 1 0.0000
557 RESPIRATORY TRACT INFECTION 1 0.0000
558 ABDOMINAL DISTENSION 4 0.0000
559 APPLICATION SITE ERYTHEMA 1 0.0000
560 MUSCLE SPASMS 7 0.0000
561 ARTHRITIS 3 0.0000
562 ANHEDONIA 1 0.0000
563 EAR INFECTION 1 0.0000
564 FEAR 1 0.0000
565 JAUNDICE 1 0.0000
566 PAIN OF SKIN 1 0.0000
567 OEDEMA 2 0.0000
568 CONSTIPATION 8 0.0000
569 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
570 ABNORMAL DREAMS 1 0.0000
571 DEMENTIA 1 0.0000
572 WOUND 1 0.0000
573 ASTHMA 4 0.0000
574 HYPERSOMNIA 1 0.0000
575 EYE IRRITATION 2 0.0000
576 BALANCE DISORDER 3 0.0000
577 ASTHENIA 13 0.0000
578 DECREASED APPETITE 8 0.0000
579 BONE PAIN 2 0.0000
580 ACUTE MYOCARDIAL INFARCTION 1 0.0000
581 LABORATORY TEST ABNORMAL 1 0.0000
582 CATARACT 2 0.0000
583 APHASIA 1 0.0000
584 LACRIMATION INCREASED 1 0.0000
585 HYPERSENSITIVITY 6 0.0000
586 LIMB DISCOMFORT 1 0.0000
587 BONE DENSITY DECREASED 1 0.0000
588 DRUG INTERACTION 5 0.0000
589 MOOD SWINGS 1 0.0000
590 GAIT DISTURBANCE 6 0.0000
591 HYPOTHYROIDISM 1 0.0000
592 INTENTIONAL OVERDOSE 2 0.0000
593 PAIN 19 0.0000
594 ALOPECIA 6 0.0000
595 CHOLELITHIASIS 1 0.0000
596 EYE DISORDER 1 0.0000
597 STAPHYLOCOCCAL INFECTION 1 0.0000
598 DIZZINESS 15 0.0000
599 SKIN DISORDER 1 0.0000
600 URINARY RETENTION 1 0.0000
601 GAIT INABILITY 1 0.0000
602 ABDOMINAL DISCOMFORT 5 0.0000
603 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
604 MYALGIA 5 0.0000
605 SINUSITIS 3 0.0000
606 ABDOMINAL PAIN UPPER 6 0.0000
607 NIGHTMARE 1 0.0000
608 DELIRIUM 1 0.0000
609 WEIGHT DECREASED 8 0.0000
610 DEVICE MALFUNCTION 2 0.0000
611 INJURY 2 0.0000
612 LYMPHADENOPATHY 1 0.0000
613 ACCIDENTAL OVERDOSE 1 0.0000
614 FALL 9 0.0000
615 SEPSIS 3 0.0000
616 HOT FLUSH 2 0.0000
617 MUSCULAR WEAKNESS 3 0.0000
618 DIABETES MELLITUS 2 0.0000
619 BLOOD PRESSURE INCREASED 4 0.0000
620 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
621 VOMITING 12 0.0000
622 DRUG DEPENDENCE 4 0.0000
623 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
624 EMOTIONAL DISTRESS 3 0.0000
625 PSORIATIC ARTHROPATHY 1 0.0000
626 DEVICE BREAKAGE 1 0.0000
627 ERYTHEMA 5 0.0000
628 VISUAL IMPAIRMENT 3 0.0000
629 DRUG ABUSE 2 0.0000
630 POLLAKIURIA 1 0.0000
631 OSTEOARTHRITIS 1 0.0000
632 URINARY TRACT INFECTION 4 0.0000
633 HYPOACUSIS 1 0.0000
634 DEVICE LEAKAGE 1 0.0000
635 VAGINAL HAEMORRHAGE 1 0.0000
636 SEPTIC SHOCK 1 0.0000
637 ANGIOEDEMA 1 0.0000
638 LIVER DISORDER 1 0.0000
639 THROAT IRRITATION 1 0.0000
640 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
641 ARTHRALGIA 9 0.0000
642 CHEST PAIN 4 0.0000
643 COMA 1 0.0000
644 PRODUCTIVE COUGH 1 0.0000
645 RASH ERYTHEMATOUS 1 0.0000
646 PRURITUS 8 0.0000
647 RASH 9 0.0000
648 HYPOTENSION 4 0.0000
649 CELLULITIS 1 0.0000
650 INJECTION SITE PAIN 6 0.0000
651 HOSPITALISATION 3 0.0000
652 THERAPY CESSATION 1 0.0000
653 ECZEMA 1 0.0000
654 MUSCULOSKELETAL PAIN 1 0.0000
655 CONFUSIONAL STATE 3 0.0000
656 ANAPHYLACTIC REACTION 1 0.0000
657 ARTHROPATHY 1 0.0000
658 INFLUENZA 2 0.0000
659 URTICARIA 3 0.0000
660 TOXICITY TO VARIOUS AGENTS 3 0.0000
661 HYPONATRAEMIA 1 0.0000
662 CEREBROVASCULAR ACCIDENT 3 0.0000
663 SEIZURE 2 0.0000
664 BACK PAIN 4 0.0000
665 DYSPHONIA 1 0.0000
666 DIARRHOEA 11 0.0000
667 PAIN IN EXTREMITY 5 0.0000
668 WHEEZING 1 0.0000
669 THERAPEUTIC RESPONSE DECREASED 1 0.0000
670 SUICIDE ATTEMPT 1 0.0000
671 STOMATITIS 1 0.0000
672 ILL-DEFINED DISORDER 1 0.0000
673 OEDEMA PERIPHERAL 2 0.0000
674 FEELING HOT 1 0.0000
675 BLOOD GLUCOSE INCREASED 3 0.0000
676 DYSPNOEA 9 0.0000
677 DEEP VEIN THROMBOSIS 1 0.0000
678 AMNESIA 1 0.0000
679 PSORIASIS 2 0.0000
680 DRY SKIN 2 0.0000
681 INJECTION SITE PRURITUS 1 0.0000
682 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
683 INJECTION SITE REACTION 1 0.0000
684 PYREXIA 5 0.0000
685 COUGH 4 0.0000
686 SKIN BURNING SENSATION 1 0.0000
687 OVERDOSE 3 0.0000
688 INFECTION 2 0.0000
689 EPISTAXIS 1 0.0000
690 INJECTION SITE SWELLING 1 0.0000
691 ABDOMINAL PAIN 3 0.0000
692 DRUG DOSE OMISSION BY DEVICE 1 0.0000
693 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
694 INFLUENZA LIKE ILLNESS 1 0.0000
695 PRODUCT STORAGE ERROR 1 0.0000
696 INTENTIONAL PRODUCT MISUSE 1 0.0000
697 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
698 CARDIAC DISORDER 1 0.0000
699 NEUROPATHY PERIPHERAL 1 0.0000
700 ANAEMIA 2 0.0000
701 CONTUSION 1 0.0000
702 ATRIAL FIBRILLATION 1 0.0000
703 HAEMOGLOBIN DECREASED 1 0.0000
704 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
705 INJECTION SITE ERYTHEMA 1 0.0000
706 MYOCARDIAL INFARCTION 1 0.0000
707 DEATH 3 0.0000
708 PNEUMONIA 1 0.0000